Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
about
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseFunctional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusionUse of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors.V3-independent competitive resistance of a dual-X4 HIV-1 to the CXCR4 inhibitor AMD3100Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching.Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.The entry of entry inhibitors: a fusion of science and medicine.Recent progress in antiretrovirals--lessons from resistanceTat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.CXCR4-dependent infection of CD8+, but not CD4+, lymphocytes by a primary human immunodeficiency virus type 1 isolate.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individualsEvidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors
P2860
Q24524292-20E330EE-AC57-4E93-812C-A898511F99C5Q24678540-97E6AC21-BB49-4A6C-AC3D-ED98CAEA9684Q33808728-DE70C347-F8F3-46B9-9679-916A088F55D7Q33886716-58AEFA47-C921-494A-B08E-5277DD16337CQ34077065-2C22A9B4-6F2F-4202-A3A2-0A8BED8A8F53Q34151017-B1A3ADC8-0307-46DB-BD70-C1447834667AQ34253200-E9B17AE5-BAF9-434A-8781-9B8A2D2A34DEQ35107518-BF39BF1A-21FF-4BE3-A835-73631920A434Q35122466-D354051C-C113-40DC-967B-FA1B41977454Q35182388-B5D86F92-FC77-417A-9F48-45018F14F8FEQ35785164-4FDDA3B0-B1AB-453D-826F-B0871C079D2EQ35976966-6C6CE467-8DF6-4DF7-8DD8-A080099F8F6FQ36967857-BE03DB18-8326-4545-9E96-4D8C77847A15Q37150920-E0F14A79-C68E-4BDD-9DB6-A672C79C5A68Q37596922-B836979D-F545-473E-9AAE-1E228A77BDE4Q38076139-6B4EEDF9-84BA-4B60-B55A-7421F76F1201Q39539977-F7A615AA-7ED8-4083-8A56-D78661054910Q39604683-DB33C61A-81A1-4EE6-950C-7B29C60C8DF8Q39605336-C3452671-F8C7-4F45-976D-CEA82702B5D1
P2860
Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@ast
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@en
type
label
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@ast
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@en
prefLabel
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@ast
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@en
P2093
P2860
P1433
P1476
Shift of clinical human immuno ...... phenotype by blockade of CXCR4
@en
P2093
P2860
P304
P577
1999-07-01T00:00:00Z